000 01121 a2200325 4500
005 20250515045516.0
264 0 _c20070801
008 200708s 0 0 eng d
022 _a0172-8172
024 7 _a10.1007/s00296-006-0254-9
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPeiró, A M
245 0 0 _aCitalopram-induced Raynaud's phenomenon.
_h[electronic resource]
260 _bRheumatology international
_cApr 2007
300 _a599-601 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAdult
650 0 4 _aAnalgesics
_xtherapeutic use
650 0 4 _aCitalopram
_xadverse effects
650 0 4 _aDepressive Disorder
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aNeuralgia
_xdrug therapy
650 0 4 _aRaynaud Disease
_xchemically induced
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
700 1 _aMargarit, C
700 1 _aTorra, M
773 0 _tRheumatology international
_gvol. 27
_gno. 6
_gp. 599-601
856 4 0 _uhttps://doi.org/10.1007/s00296-006-0254-9
_zAvailable from publisher's website
999 _c16675523
_d16675523